FSD Pharma Inc. (HUGE)
| Market Cap | 60.69M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -24.94M |
| Shares Out | 35.99M |
| EPS (ttm) | -2.07 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | May 7 |
| Last Price | $1.70 |
| Previous Close | $1.59 |
| Change ($) | 0.11 |
| Change (%) | 6.92% |
| Day's Open | 1.65 |
| Day's Range | 1.62 - 1.70 |
| Day's Volume | 352,505 |
| 52-Week Range | 1.28 - 14.00 |
FSD Pharma Inc. (NASDAQ:HUGE) (CSE:HUGE) has announced the appointment of Nathan Coyle, the company's corporate controller as its interim chief financial officer with immediate effect, following the dep...
TORONTO--(BUSINESS WIRE)---- $HUGE--FSD Pharma Inc. (Nasdaq:HUGE) (CSE:HUGE) (the "Company" or "FSD Pharma") is pleased to announce the appointment of Nathan Coyle, the Company's Corporate Controller as...
TORONTO--(BUSINESS WIRE)---- $HUGE--FSD Pharma Inc. (Nasdaq:HUGE) (CSE:HUGE) (the "Company" or "FSD Pharma") wishes to alert you to the events that have occurred since the Company filed its Management I...
Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week, and look ahead to how the cannabis industry will conti...
Toronto, Ontario--(Newsfile Corp. - April 26, 2021) - On Monday, April 26, 2021, the group of concerned shareholders (the "Concerned Shareholders") of FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K...
TORONTO--(BUSINESS WIRE)---- $HUGE--FSD Pharma Inc. (Nasdaq:HUGE) (CSE:HUGE) (the "Company" or "FSD Pharma") announces the filing of its Management Information Circular (the "Circular") and an accompany...
Focused on lead anti-inflammatory drug FSD-201 Launched Phase 2 study of drug known as micro PEA in December 2020 Developing drugs to treat gastrointestinal diseases in dogs and cats What FSD Pharma doe...
Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week, and look ahead to how the cannabis industry will conti...
TORONTO, April 5, 2021 /PRNewswire/ - On Tuesday, March 30, 2021, Anthony Durkacz, a founding director and member of the group of concerned shareholders, which also includes founding shareholder Zeeshan...
Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week, and look ahead to how the cannabis industry will conti...
TORONTO--(BUSINESS WIRE)---- $HUGE #FSD--FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE) (“FSD Pharma” or the “Company”) today announced that it has commenced an application in the Ontario Superior Court see...
bluebird bio, Inc. (NASDAQ: BLUE), Onconova Therapeutics, Inc. (NASDAQ: ONTX), FSD Pharma Inc. (NASDAQ: HUGE) and Immatics N.V. (NASDAQ: IMTX) are among the biggest biopharma movers in Wednesday's session.
FSD Pharma Inc (NASDAQ:HUGE) (CSE:HUGE) (FRA:0K9A) has entered into a license agreement with Innovet Italia SRL to develop US Food and Drug Administration-approved veterinary drugs for the treatment of ...
HUGE stock is on the move Wednesday after FSD Pharma announced a potentially lucrative move in the pet care market. Here's what to know.
TORONTO--(BUSINESS WIRE)---- $HUGE--FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE) (“FSD Pharma” or the “Company”) today announces that it has entered into a license agreement (the “License Agreement”) with...
Toronto, Ontario--(Newsfile Corp. - March 8, 2021) - The group of concerned shareholders (the "Concerned Shareholders") of FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9) (the "Company" or "FSD") ...
Welcome back to our weekly series, Sc haeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week, and look ahead to how the cannabis industry will cont...
FSD Pharma Inc. (NASDAQ:HUGE) (CSE:HUGE) said it has entered into an equity sales agreement with A.G.P./Alliance Global Partners covering the sale of Class B subordinate voting shares of the company on ...
TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (Nasdaq:HUGE) (CSE:HUGE) ("FSD Pharma" or the "Company") today announced that it has entered into an Equity Distribution Agreement dated February 11, 2021 (the ...
Welcome back to our weekly series, Sc haeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week, and look ahead to how the cannabis industry will deve...
TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE) (“FSD Pharma” or the “Company”) today announces the following corporate updates. Corporate Update The Company continues to pursue its...
TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (Nasdaq:HUGE) (CSE:HUGE) (“FSD Pharma” or the “Company”) today announced that it will hold its annual meeting of shareholders (the “Meeting”) on June 29, 2021. ...
TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE) (“FSD Pharma” or the “Company”) today announced the dosing of the first patient in its Phase 2a clinical trial of FSD201 (ultramicron...
Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week and we will look ahead at the pot stocks to watch in th...
TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE) (“FSD Pharma” or the “Company”) today announced its financial results for the third quarter ending September 30, 2020 and provided a ...
TORONTO--(BUSINESS WIRE)-- #FSDPharma--FSD Pharma Inc. (NASDAQ:HUGE) (CSE:HUGE) ("FSD Pharma" or the "Company") today announced that, subject to court certification and other customary conditions, it ha...
TORONTO--(BUSINESS WIRE)-- #HUGE--FSD Pharma Inc. (Nasdaq: HUGE) (“FSD Pharma” or the “Company”), today announced the closing of previously announced definitive agreements with investors for the purchas...
TORONTO--(BUSINESS WIRE)-- #FSDDF--FSD Pharma Inc. (Nasdaq: HUGE) (“FSD Pharma” or the “Company”), today announced that it has entered into definitive agreements with investors for the purchase and sale...
TORONTO--(BUSINESS WIRE)-- #FSDDF--FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (“FSD Pharma” or the “Company”) announced that the U.S. Food and Drug Administration (“FDA”) has authorized the initiatio...
TORONTO--(BUSINESS WIRE)-- #FSDDF--FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (“FSD Pharma” or the “Company”) today announced that it has submitted to the U.S.
TORONTO--(BUSINESS WIRE)-- #FSDDF--FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (FRA: 0K9A) (“FSD Pharma” or the “Company”) today reported that management’s discussion and analysis of financial conditi...
TORONTO--(BUSINESS WIRE)-- #FSDDF--FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (“FSD Pharma” or the “Company”) announces the closing of a previously announced agreement with investors for the purchase...
Vancouver, British Columbia--(Newsfile Corp. - July 31, 2020) - FSD Pharma Inc.
TORONTO--(BUSINESS WIRE)-- #FSDDF--FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (“FSD Pharma” or the “Company”), today announced that it has entered into definitive agreements with investors for the pu...
TORONTO--(BUSINESS WIRE)-- #FSDDF--FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (FRA: 0K9A) (“FSD Pharma” or the “Company”) today announced that it has notified Health Canada of the Company’s decision ...
TORONTO--(BUSINESS WIRE)-- #FSDDF--FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (“FSD Pharma” or the “Company”) today announced that it has entered into an Equity Distribution Agreement dated July 10, ...
Vancouver, British Columbia--(Newsfile Corp. - June 23, 2020) - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9), a specialty, biotech pharmaceutical R&D company, focused on developing, over time...
TORONTO--(BUSINESS WIRE)-- #FSDDF--FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (FRA: 0K9A) (“FSD Pharma” or the "Company") today announced favorable topline results from its Phase 1 randomized, double...
FSD Pharma Jumps On COVID-19 Trial Progress, And Other News: The Good, Bad And Ugly Of Biopharma
Shares of FSD Pharma tripled Wednesday after the small-cap biotech company announced plans to study a potential coronavirus treatment. The drug is called ultramicronized PEA.
FSD Pharma Inc. (NASDAQ: HUGE) shares absolutely exploded on Wednesday morning after the company received a key update from the U.S.
Shares of FSD Pharma Inc (NASDAQ: HUGE) are advancing strongly Wednesday following an announcement regarding a potential COVID-19 drug.
FSD Pharma Inc (NASDAQ: HUGE) has netted itself more than $7.7 million through the sale of its 12% equity interest in Cannara Biotech Inc (OTC: LOVFF) to a consortium of that included entities controlle...
FSD Pharma Inc (CSE: HUGE) (OTC: FSDDF) said Monday that its Class B Subordinate Voting Shares have been accepted for listing on the NASDAQ Capital Market under the ticker "HUGE.
FSD Pharma Inc. (CSE: HUGE) (OTC: FSDDF) said Monday it has obtained approval for its Class B subordinate shares to list on the Nasdaq Capital Market.
About HUGE
FSD Pharma Inc., through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD 201 that is in the Phase II clinical trial to treat COVID-19 disease. The company also develops drugs for the treatment of pain, inflammation, and neurological disorders. It has license agreements with Epitech Group SpA.; and with Innovet Italia S.R.L. to develop veterinary drugs for the treatment of gastro-intestinal diseases in dogs and cats. The company was founded in 1998 and is headquartered in Toronto, ... [Read more...]
| Industry Drug Manufacturers-Specialty & Generic | Founded 1998 |
| CEO Raza Bokhari | Employees 9 |
| Stock Exchange NASDAQ | Ticker Symbol HUGE |